A retiree on a fixed income can face a stark choice at the pharmacy counter when a prescription’s price climbs past what the monthly budget allows. A federal program tied to Medicare Part D is built to remove that pressure for people with limited means, holding the out-of-pocket cost of covered medications to a few dollars each. In 2026 it can wipe out the Part D deductible and keep brand-name copays well under twenty dollars, turning an unaffordable drug list into a manageable one.
What Extra Help caps drug costs at in 2026
The program, formally the Part D Low-Income Subsidy, limits what enrollees pay when they fill a covered prescription. For 2026, the standard subsidy holds copays to no more than $5.10 for a generic drug and $12.65 for a brand-name drug. Beyond the copay cap, the assistance reduces or eliminates the Part D deductible and pays the plan’s monthly premium up to a regional benchmark amount, so a qualifying beneficiary can often carry little or no premium cost for drug coverage.
The precise mechanics matter. Whether the deductible disappears entirely or is merely lowered depends on the beneficiary’s income tier, and premium help extends only up to the benchmark, meaning a plan priced above that line could leave a small residual premium. The consistent effect across qualifying enrollees is the same, though: the unpredictable, sometimes crippling cost of a long medication list is replaced by fixed, modest copays that a fixed income can absorb.
The copay ceilings are federal maximums rather than one insurer’s pricing, so a qualifying enrollee generally sees the same low cost structure no matter which participating Part D plan they select. The figures are also refreshed each year, which means the 2026 amounts of $5.10 and $12.65 replace slightly lower prior-year ceilings and will shift again for 2027. For a beneficiary comparing plans during the fall enrollment period, that uniformity simplifies the decision, because the drug-cost side is largely set by the subsidy tier rather than by any single plan’s cost-sharing schedule.
Free retirement updates: Social Security and Medicare change every year, and nobody sends you a memo. Our free Retirement Shield newsletter breaks down what changed and what to do. Get it free in your inbox.
Dual-eligible enrollees pay even less
People who qualify for both Medicare and Medicaid, and whose income falls below the poverty line, sit in the deepest subsidy tier. For that group in 2026, copays drop further, to as little as $1.60 for a generic and $4.90 for a brand-name drug. The subsidy is structured in levels, so the amount a person pays scales with how far their income and resources fall below the thresholds, and the lowest-income enrollees see the smallest bills.
The dual-eligible tier illustrates how the benefit is designed to concentrate the most help where the need is greatest. For someone managing several chronic conditions with multiple daily prescriptions, the difference between a full-price formulary and copays measured in single dollars can decide whether the medications get filled at all. That is the practical stake behind the numbers.
The 2026 income and resource limits that decide eligibility
Eligibility turns on two tests, one for income and one for countable resources. In 2026, an applicant generally qualifies with income below 150 percent of the federal poverty level, which works out to $23,940 for a single person and $32,460 for a married couple. The resource test allows up to $16,590 in countable assets for an individual and $33,100 for a couple, and a primary home and one vehicle are excluded from that count. Medicare directs beneficiaries to the programs that help pay drug and other costs, and the Social Security Administration processes Extra Help applications.
The exclusion of a home and a vehicle is a detail that trips up many would-be applicants, who assume owning a house disqualifies them. It does not. A homeowner living on a modest Social Security check may well fall within the resource limit once the house and car are set aside, which means a substantial number of people who could qualify never apply because they wrongly assume they earn or own too much.
Because the thresholds are updated each year and the resource rules are specific about what counts, an applicant near the margins in one year may qualify in the next as the limits rise. The figures cited here are the 2026 numbers; the structure, an income test tied to the poverty level paired with a countable-resource cap that ignores the home and a car, carries forward from year to year.
For a household weighing whether the paperwork is worth it, the arithmetic over a full year is stark. A retiree filling several brand-name and generic prescriptions each month can face hundreds of dollars in drug spending at full price, while under Extra Help those same fills are held to the modest per-drug copays and the deductible that would otherwise front-load the year’s cost is reduced or removed entirely. The savings compound across every prescription and every month, which is why the subsidy is often worth far more than its small-sounding copay figures suggest at a glance.
The larger point is that Extra Help is one of the more valuable and most underused benefits available to lower-income Medicare enrollees. It does not require giving up a current drug plan or switching insurers; it layers on top of Part D coverage to cut the cost of filling prescriptions. For a household weighing whether to ration medication against other bills, confirming eligibility against the 2026 income and resource limits is the step that unlocks the fixed, low copays the program guarantees.
This article was produced with AI assistance and reviewed against primary sources by The Money Overview editorial team.
More Financial Reading
